The stents market size has grown strongly in recent years. It will grow from $11.81 billion in 2025 to $12.49 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to limited stent material options, reliance on bare-metal stents, increasing prevalence of coronary artery disease, growing hospital infrastructure, adoption of angioplasty procedures.
The stents market size is expected to see strong growth in the next few years. It will grow to $15.62 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to development of drug-eluting and bioabsorbable stents, expansion of neurovascular and peripheral interventions, rising investment in stent R&D, increasing aging population with cardiovascular conditions, integration of smart and AI-assisted stent deployment systems. Major trends in the forecast period include rising adoption of drug-eluting and bioabsorbable stents, increasing use of peripheral and neurovascular stents, focus on minimally invasive procedures and endovascular surgeries, growing demand for customized stent designs and materials, enhanced regulatory compliance and post-market surveillance.
The increasing prevalence of cardiovascular disorders is expected to drive the growth of the stents market in the future. Cardiovascular disorders are health conditions that affect the heart or blood vessels, impairing the heart's function. The rise in these disorders is linked to factors such as physical inactivity, which can lead to obesity, high blood pressure, and poor cardiovascular health by reducing the efficiency of the heart and circulation. Stent placement helps by restoring blood flow in narrowed or blocked arteries, thus reducing the risk of heart attacks and other complications. For example, in January 2025, the British Heart Foundation reported that 7.6 million people in the UK were living with heart and circulatory diseases, accounting for nearly 27% of all deaths in the country, resulting in over 170,000 fatalities annually. As a result, the growing prevalence of cardiovascular disorders is fueling the growth of the stent market.
Major companies operating in the stent market are emphasizing the development of innovative technologies such as drug-eluting stents to improve treatment effectiveness, lower restenosis rates, and enhance patient outcomes. Drug-eluting stents are small mesh tubes placed in arteries that gradually release medication to prevent the vessel from narrowing again after intervention. For example, in April 2023, Terumo Europe N.V., a Belgium-based medical device company, introduced the Ultimaster Nagomi sirolimus-eluting coronary stent system for complex percutaneous coronary intervention (PCI) cases following CE mark approval. The system is engineered to improve deliverability in challenging anatomies, enable shorter dual antiplatelet therapy (DAPT) regimens for patients at high risk of bleeding, and preserve optimal radial strength. It also incorporates advanced polymer technology to ensure controlled drug release and promote improved endothelial healing.
In January 2024, Olympus Corporation, a Japanese manufacturer of optics and reprography products, acquired Taewoong Medical Co. Ltd. for $370 million. With this acquisition, Olympus aims to strengthen its position in the gastrointestinal market by expanding its portfolio of innovative therapeutic stents and enhancing its presence in the global medical device industry. Taewoong Medical specializes in manufacturing gastrointestinal metallic stents and will help Olympus provide comprehensive solutions for gastrointestinal disorders.
Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical, Biotronik SE and Co KG, MicroPort Scientific Corporation, Meril Life Sciences, Biosensors International Group Ltd, Elixir Medical Corporation, Veryan Medical Limited, Vascular Concepts Ltd, Novatech SA, Merit Medical Systems Inc, Teleflex Incorporated, Micro Tech Europe, Balton Sp z oo, Endologix Inc, Cardinal Health Interventional, Nipro Medical Corporation, Optimed Medizinische Instrumente GmbH.
North America was the largest region in the stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the stents market by raising costs for imported metallic and polymer biomaterials used in manufacturing, impacting segments like coronary and peripheral stents. Regions such as Asia-Pacific, including China and India, which serve as major production and export hubs, are particularly affected. This has led to higher manufacturing costs and supply chain disruptions. Positively, tariffs have encouraged local production, innovation in material alternatives, and investment in domestic stent manufacturing capabilities.
The stents market research report is one of a series of new reports that provides stents market statistics, including stents industry global market size, regional shares, competitors with a stents market share, detailed stents market segments, market trends and opportunities, and any further data you may need to thrive in the stents industry. This stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A stent is a small, mesh-like device that is inserted into a narrowed or blocked blood vessel to help maintain its openness and ensure proper blood circulation. It is commonly used in medical procedures to treat conditions such as coronary artery disease and to prevent arteries from collapsing after balloon angioplasty.
The primary types of stents include coronary stents, peripheral stents, stent-related implants, biliary stents, carotid stents, and neurovascular stents. Coronary stents are tiny mesh tubes inserted into the arteries of the heart to keep them open when they become blocked or narrowed due to plaque buildup. These stents are made from various materials, including metallic, polymer, and natural biomaterials, and are used by a range of end users such as hospitals, clinics, ambulatory surgical centers, and others.
The stents market consists of sales of products such as renal artery stents, ureteral stents, and gastrointestinal stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The stents market size is expected to see strong growth in the next few years. It will grow to $15.62 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to development of drug-eluting and bioabsorbable stents, expansion of neurovascular and peripheral interventions, rising investment in stent R&D, increasing aging population with cardiovascular conditions, integration of smart and AI-assisted stent deployment systems. Major trends in the forecast period include rising adoption of drug-eluting and bioabsorbable stents, increasing use of peripheral and neurovascular stents, focus on minimally invasive procedures and endovascular surgeries, growing demand for customized stent designs and materials, enhanced regulatory compliance and post-market surveillance.
The increasing prevalence of cardiovascular disorders is expected to drive the growth of the stents market in the future. Cardiovascular disorders are health conditions that affect the heart or blood vessels, impairing the heart's function. The rise in these disorders is linked to factors such as physical inactivity, which can lead to obesity, high blood pressure, and poor cardiovascular health by reducing the efficiency of the heart and circulation. Stent placement helps by restoring blood flow in narrowed or blocked arteries, thus reducing the risk of heart attacks and other complications. For example, in January 2025, the British Heart Foundation reported that 7.6 million people in the UK were living with heart and circulatory diseases, accounting for nearly 27% of all deaths in the country, resulting in over 170,000 fatalities annually. As a result, the growing prevalence of cardiovascular disorders is fueling the growth of the stent market.
Major companies operating in the stent market are emphasizing the development of innovative technologies such as drug-eluting stents to improve treatment effectiveness, lower restenosis rates, and enhance patient outcomes. Drug-eluting stents are small mesh tubes placed in arteries that gradually release medication to prevent the vessel from narrowing again after intervention. For example, in April 2023, Terumo Europe N.V., a Belgium-based medical device company, introduced the Ultimaster Nagomi sirolimus-eluting coronary stent system for complex percutaneous coronary intervention (PCI) cases following CE mark approval. The system is engineered to improve deliverability in challenging anatomies, enable shorter dual antiplatelet therapy (DAPT) regimens for patients at high risk of bleeding, and preserve optimal radial strength. It also incorporates advanced polymer technology to ensure controlled drug release and promote improved endothelial healing.
In January 2024, Olympus Corporation, a Japanese manufacturer of optics and reprography products, acquired Taewoong Medical Co. Ltd. for $370 million. With this acquisition, Olympus aims to strengthen its position in the gastrointestinal market by expanding its portfolio of innovative therapeutic stents and enhancing its presence in the global medical device industry. Taewoong Medical specializes in manufacturing gastrointestinal metallic stents and will help Olympus provide comprehensive solutions for gastrointestinal disorders.
Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical, Biotronik SE and Co KG, MicroPort Scientific Corporation, Meril Life Sciences, Biosensors International Group Ltd, Elixir Medical Corporation, Veryan Medical Limited, Vascular Concepts Ltd, Novatech SA, Merit Medical Systems Inc, Teleflex Incorporated, Micro Tech Europe, Balton Sp z oo, Endologix Inc, Cardinal Health Interventional, Nipro Medical Corporation, Optimed Medizinische Instrumente GmbH.
North America was the largest region in the stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the stents market by raising costs for imported metallic and polymer biomaterials used in manufacturing, impacting segments like coronary and peripheral stents. Regions such as Asia-Pacific, including China and India, which serve as major production and export hubs, are particularly affected. This has led to higher manufacturing costs and supply chain disruptions. Positively, tariffs have encouraged local production, innovation in material alternatives, and investment in domestic stent manufacturing capabilities.
The stents market research report is one of a series of new reports that provides stents market statistics, including stents industry global market size, regional shares, competitors with a stents market share, detailed stents market segments, market trends and opportunities, and any further data you may need to thrive in the stents industry. This stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A stent is a small, mesh-like device that is inserted into a narrowed or blocked blood vessel to help maintain its openness and ensure proper blood circulation. It is commonly used in medical procedures to treat conditions such as coronary artery disease and to prevent arteries from collapsing after balloon angioplasty.
The primary types of stents include coronary stents, peripheral stents, stent-related implants, biliary stents, carotid stents, and neurovascular stents. Coronary stents are tiny mesh tubes inserted into the arteries of the heart to keep them open when they become blocked or narrowed due to plaque buildup. These stents are made from various materials, including metallic, polymer, and natural biomaterials, and are used by a range of end users such as hospitals, clinics, ambulatory surgical centers, and others.
The stents market consists of sales of products such as renal artery stents, ureteral stents, and gastrointestinal stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Stents Market Characteristics
3. Stents Market Supply Chain Analysis
4. Global Stents Market Trends and Strategies
5. Stents Market Analysis of End Use Industries
7. Global Stents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Stents Total Addressable Market (TAM) Analysis for the Market
9. Stents Market Segmentation
10. Stents Market Regional and Country Analysis
11. Asia-Pacific Stents Market
12. China Stents Market
13. India Stents Market
14. Japan Stents Market
15. Australia Stents Market
16. Indonesia Stents Market
17. South Korea Stents Market
18. Taiwan Stents Market
19. South East Asia Stents Market
20. Western Europe Stents Market
21. UK Stents Market
22. Germany Stents Market
23. France Stents Market
24. Italy Stents Market
25. Spain Stents Market
26. Eastern Europe Stents Market
27. Russia Stents Market
28. North America Stents Market
29. USA Stents Market
30. Canada Stents Market
31. South America Stents Market
32. Brazil Stents Market
33. Middle East Stents Market
34. Africa Stents Market
36. Stents Market Competitive Landscape and Company Profiles
37. Stents Market Other Major and Innovative Companies
40. Stents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Stents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Coronary Stents; Peripheral Stents; Stent-Related Implants; Biliary Stents; Carotid Stents; Neurovascular Stents2) By Material: Metallic Biomaterial; Polymer Biomaterial
3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Other End User
Subsegments:
1) By Coronary Stents: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents2) By Peripheral Stents: Iliac Artery Stents; Femoral-Popliteal Artery Stents; Renal Artery Stents; Tibial Artery Stents
3) By Stent-Related Implants: Stent Grafts; Endovascular Stent Grafts; Covered Stents
4) By Biliary Stents: Plastic Biliary Stents; Metallic Biliary Stents; Self-Expanding Biliary Stents
5) By Carotid Stents: Balloon-Expandable Carotid Stents; Self-Expanding Carotid Stents
6) By Neurovascular Stents: Flow Diverter Stents; Self-Expanding Neurovascular Stents; Balloon-Expandable Neurovascular Stents
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical; Biotronik SE and Co KG; MicroPort Scientific Corporation; Meril Life Sciences; Biosensors International Group Ltd; Elixir Medical Corporation; Veryan Medical Limited; Vascular Concepts Ltd; Novatech SA; Merit Medical Systems Inc; Teleflex Incorporated; Micro Tech Europe; Balton Sp z oo; Endologix Inc; Cardinal Health Interventional; Nipro Medical Corporation; Optimed Medizinische Instrumente GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Stents market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Terumo Corporation
- B Braun Melsungen AG
- Cook Medical
- Biotronik SE and Co KG
- MicroPort Scientific Corporation
- Meril Life Sciences
- Biosensors International Group Ltd
- Elixir Medical Corporation
- Veryan Medical Limited
- Vascular Concepts Ltd
- Novatech SA
- Merit Medical Systems Inc
- Teleflex Incorporated
- Micro Tech Europe
- Balton Sp z oo
- Endologix Inc
- Cardinal Health Interventional
- Nipro Medical Corporation
- Optimed Medizinische Instrumente GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.49 Billion |
| Forecasted Market Value ( USD | $ 15.62 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
